QSAR and Molecular Modeling Studies in Heterocyclic Drugs. Part - II (Record no. 16179)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00934nam a2200169Ia 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 140223b2006 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783540332336 |
| Terms of availability | 0.00 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 547.59 |
| Item number | QSA |
| 245 ## - TITLE STATEMENT | |
| Title | QSAR and Molecular Modeling Studies in Heterocyclic Drugs. Part - II |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Heidelberg |
| Name of publisher, distributor, etc | Springer-Verlag |
| Date of publication, distribution, etc | 2006 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 296p |
| 500 ## - GENERAL NOTE | |
| General note | Topics in Heterocyclic Chemistry, Volume 4> Presents critical accounts of heterocyclic compounds. Topics include QSAR and molecular modeling studies of factor Xa and thrombin inhibitors; structural information and drug-enzyme interaction of the non-nucleoside reverse transcriptase inhibitors based on computational chemistry approaches; and more. For researchers. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Personal name | Heterocyclic Chemistry |
| 9 (RLIN) | 15477 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gupta, Satya Prakash |
| Relator term | Editor |
| 9 (RLIN) | 17151 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Item type | Book |
| Call number prefix | 547.59 |
| Call number suffix | QSA |
| 995 ## - RECOMMENDATION 995 [LOCAL, UNIMARC FRANCE] | |
| Origin of item (home branch) (free text) | Pharmacy Reference |
| Genre | P0005201 |
| Section | 547.59 |
| Recipient parent organisation code | P0005201 |
No items available.